GlassScriptPhysician profile
Hovig K Artinian
NPI 1093014284
$3,744.69
in general payments reported to CMS, 2019-2025
23 companies · $664 in 2025
The $664 reported for 2025 was more than what 82% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $908 · 2020: $124 · 2021: $557 · 2022: $99.94 · 2023: $942 · 2024: $450 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,904 · Education: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,904.42 |
| Education | $151.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $1,017.36 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $447.85 | 2023-2025 | Tezspire, Fasenra |
| Philips North America LLC | $428.28 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Vertex Pharmaceuticals Incorporated | $316.33 | 2019-2025 | Trikafta |
| Harmony Biosciences LLC | $261.77 | 2024-2025 | |
| Genzyme Corporation | $224.47 | 2021-2023 | |
| Allergan, INC. | $137.52 | 2019 | |
| Zoll Respicardia, INC. | $136.53 | 2019 | |
| Glaxosmithkline, LLC. | $124.99 | 2021 | |
| Baxter Healthcare | $123.32 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Incyte Corporation | $123.09 | 2025 | Opzelura |
| Amgen INC. | $105.94 | 2023 | Tezspire |
| Resmed Corp | $66.11 | 2019-2021 | |
| Mylan Specialty L.P. | $51.44 | 2022-2023 | Tobi Podhaler |
| Pari Respiratory Equipment, INC. | $43.33 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $19.77 | 2021 | |
| Abbvie INC. | $19.55 | 2022 | |
| Pharming Healthcare, INC. | $19.41 | 2022 | |
| Sobi, INC | $19.13 | 2022 | |
| Vapotherm INC | $15.91 | 2021 | |
| Covis Pharma Gmbh | $15.36 | 2022 | |
| Gilead Sciences, INC. | $14.96 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hovig Artinian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.